0.00Open0.35Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-0.46%PremiumMay 17, 2024Expiry Date0.34Intrinsic Value100Multiplier-5DDays to Expiry0.01Time Value100Contract SizeAmericanOptions Type--Delta--Gamma6.17Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Invivyd Stock Discussion
Invivyd To Pursue Rapid Immunobridging Pathway To Potential EUA For Treatment Of COVID-19 In Moderately To Severely Immunocompromised People, Based On U.S. FDA Feedback
No comment yet